Alumis, Inc. (ALMS)
6.73
-0.16
(-2.32%)
USD |
NASDAQ |
Oct 30, 16:00
6.74
+0.01
(+0.15%)
After-Hours: 20:00
Alumis Cash and Short Term Investments (Annual) : 308.58M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 308.58M |
| December 31, 2024 | 288.26M |
| Date | Value |
|---|---|
| December 31, 2023 | 49.06M |
| December 31, 2022 | 93.07M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 20.10B |
| Corcept Therapeutics, Inc. | 372.15M |
| Aclaris Therapeutics, Inc. | 90.75M |
| BioAge Labs, Inc. | 281.10M |
| ANI Pharmaceuticals, Inc. | 294.75M |